85 results
Page 3 of 5
6-K
EX-99.1
ni7n lcohm5fmkykw
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
F-3
gxxiwru
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
rfs4mlocjc qhp3xg
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
POS AM
0g87k5z
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
00kmcin51em
5 Jul 19
Current report (foreign)
9:00am
6-K
EX-99.1
423xz8 v2mp
21 May 19
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
7:31am
6-K
EX-99.1
i3l2 hr9ctv4c65q
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
u69s1 cjwbl49hx
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
98fg80o
31 Dec 18
Current report (foreign)
8:00am
6-K
q7u7gqji1x673s54kv
15 Oct 18
Current report (foreign)
5:15pm
POS AM
sf8 6t34dr1jy
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
6-K
EX-99.1
radcm 97w
11 Oct 18
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
7:42am
6-K
EX-99.1
p83vp7
9 Oct 18
Current report (foreign)
5:21pm
424B5
829zl hgjm
5 Oct 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
f5cf42blz8vgfi
4 Oct 18
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
11:00am
6-K
EX-99.1
z7dpiu4z fjs
3 Oct 18
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
5:15pm
424B5
baf371
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
h3zr24ol gg
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.1
nu6 9wo9u4gf0p
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am